Skip to content

A study to be conducted to compare 0.25 percent levobupivacaine with 0.25 percent bupivacaine in ultrasound guided suprainguinal fascia iliaca compartment block for postoperative analgesia in elective proximal femur fracture surgeries under the effect of spinal anaesthesia

Comparision between levobupivacaine 0.25 percent versus bupivacaine 0.25 percent in ultrasound guided suprainguinal fascia iliaca compartment block for post operative analgesia in proximal femur fracture surgeries under spinal anaesthesia - a prospective randomised study - nil

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/088830
Enrollment
80
Registered
2025-06-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: USG guided Suprainguinal fascia iliaca compartment block with levobupivacaine and dexamethasone: USG Guided Suprainguinal Fascia Iliaca Compartment Block with 0.25 % levobupivacaine 38m

Sponsors

Sardar Patel Medical College Bikaner Rajasthan India
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Neck of femur fracture surgeries, Intertrochanteric femur fracture surgeries, proximal 1/3rd shaft of femur fracture surgeries ASA Grade 1 and 2

Exclusion criteria

Exclusion criteria: Patient refusal Coagulopathy or bleeding disorders Infection at the site of injection. Severe systemic illness or unstable medical condition. Uncontrolled psychiatric illness or cognitive impairment affecting informed consentor cooperation during the procedure. Pregnancy, unless deemed necessary and safe by a healthcare provider. Known anatomical abnormalities or previous surgery. Allergy or hypersensitivity to bupivacaine and levobupivacaine. Concurrent use of medications or substances that could interact with local anaesthetics or affect the outcomes of the block.

Design outcomes

Primary

MeasureTime frame
To assess the onset of sensory block. To assess duration of post operative analgesia via VAS score. Timepoint: Time points Assessment for onset sensory block - within 30 minutes after administration of the nerve block Time points to assess post operative analgesia- 30 minuites, 1 hour, 2hours, 6 hours, 12 hours, 24 hours

Secondary

MeasureTime frame
To calculate total analgesic consumption in first 24 hr post operatively. To observe any complications and side effects Timepoint: till 24hr postop period

Countries

India

Contacts

Public ContactDr Kanta Bhati

Sardar Patel Medical College

drkantabhati67@gmail.com9413466688

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026